This report aims to provide a comprehensive presentation of the global market for Candidiasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candidiasis Therapeutics. This report contains market size and forecasts of Candidiasis Therapeutics in global, including the following market information:
Global Candidiasis Therapeutics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Candidiasis Therapeutics Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Candidiasis Therapeutics companies in 2022 (%)
The global Candidiasis Therapeutics market was valued at US$ 3095.1 million in 2022 and is projected to reach US$ 3822.7 million by 2029, at a CAGR of 3.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Doxorubicin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Candidiasis Therapeutics include Novartis AG, Amgen, F. Hoffmann-La Roche Ltd., Bayer-Algeta, Merrion Pharmaceuticals Plc., Ablynx, Genta Incorporated, Galapagos NV and Catena Pharmaceuticals Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Candidiasis Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Candidiasis Therapeutics Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Candidiasis Therapeutics Market Segment Percentages, by Type, 2022 (%)
Doxorubicin
Cisplatin
7Carboplatin
Etoposide
Ifosfamide
Cyclophosphamide
Methotrexate
Vincristine
Global Candidiasis Therapeutics Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Candidiasis Therapeutics Market Segment Percentages, by Application, 2022 (%)
Multispecialty Hospitals
Cancer Research Institutes
Others
Global Candidiasis Therapeutics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Candidiasis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Candidiasis Therapeutics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Candidiasis Therapeutics revenues share in global market, 2022 (%)
Key companies Candidiasis Therapeutics sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Candidiasis Therapeutics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Amgen
F. Hoffmann-La Roche Ltd.
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Ablynx
Genta Incorporated
Galapagos NV
Catena Pharmaceuticals Inc.
Digna Biotech S.L.
Medivir AB
Amura Holdings
Outline of Major Chapters:
Chapter 1: Introduces the definition of Candidiasis Therapeutics, market overview.
Chapter 2: Global Candidiasis Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Candidiasis Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Candidiasis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Candidiasis Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Candidiasis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Candidiasis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Candidiasis Therapeutics Overall Market Size
2.1 Global Candidiasis Therapeutics Market Size: 2022 VS 2030
2.2 Global Candidiasis Therapeutics Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Candidiasis Therapeutics Sales: 2018-2030
3 Company Landscape
3.1 Top Candidiasis Therapeutics Players in Global Market
3.2 Top Global Candidiasis Therapeutics Companies Ranked by Revenue
3.3 Global Candidiasis Therapeutics Revenue by Companies
3.4 Global Candidiasis Therapeutics Sales by Companies
3.5 Global Candidiasis Therapeutics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Candidiasis Therapeutics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Candidiasis Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Candidiasis Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Candidiasis Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Candidiasis Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Candidiasis Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Doxorubicin
4.1.3 Cisplatin
4.1.4 7Carboplatin
4.1.5 Etoposide
4.1.6 Ifosfamide
4.1.7 Cyclophosphamide
4.1.8 Methotrexate
4.1.9 Vincristine
4.2 By Type - Global Candidiasis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Candidiasis Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Candidiasis Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Candidiasis Therapeutics Revenue Market Share, 2018-2030
4.3 By Type - Global Candidiasis Therapeutics Sales & Forecasts
4.3.1 By Type - Global Candidiasis Therapeutics Sales, 2018-2023
4.3.2 By Type - Global Candidiasis Therapeutics Sales, 2024-2030
4.3.3 By Type - Global Candidiasis Therapeutics Sales Market Share, 2018-2030
4.4 By Type - Global Candidiasis Therapeutics Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Candidiasis Therapeutics Market Size, 2022 & 2030
5.1.2 Multispecialty Hospitals
5.1.3 Cancer Research Institutes
5.1.4 Others
5.2 By Application - Global Candidiasis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Candidiasis Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Candidiasis Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Candidiasis Therapeutics Revenue Market Share, 2018-2030
5.3 By Application - Global Candidiasis Therapeutics Sales & Forecasts
5.3.1 By Application - Global Candidiasis Therapeutics Sales, 2018-2023
5.3.2 By Application - Global Candidiasis Therapeutics Sales, 2024-2030
5.3.3 By Application - Global Candidiasis Therapeutics Sales Market Share, 2018-2030
5.4 By Application - Global Candidiasis Therapeutics Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Candidiasis Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Candidiasis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Candidiasis Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Candidiasis Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Candidiasis Therapeutics Revenue Market Share, 2018-2030
6.3 By Region - Global Candidiasis Therapeutics Sales & Forecasts
6.3.1 By Region - Global Candidiasis Therapeutics Sales, 2018-2023
6.3.2 By Region - Global Candidiasis Therapeutics Sales, 2024-2030
6.3.3 By Region - Global Candidiasis Therapeutics Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Candidiasis Therapeutics Revenue, 2018-2030
6.4.2 By Country - North America Candidiasis Therapeutics Sales, 2018-2030
6.4.3 US Candidiasis Therapeutics Market Size, 2018-2030
6.4.4 Canada Candidiasis Therapeutics Market Size, 2018-2030
6.4.5 Mexico Candidiasis Therapeutics Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Candidiasis Therapeutics Revenue, 2018-2030
6.5.2 By Country - Europe Candidiasis Therapeutics Sales, 2018-2030
6.5.3 Germany Candidiasis Therapeutics Market Size, 2018-2030
6.5.4 France Candidiasis Therapeutics Market Size, 2018-2030
6.5.5 U.K. Candidiasis Therapeutics Market Size, 2018-2030
6.5.6 Italy Candidiasis Therapeutics Market Size, 2018-2030
6.5.7 Russia Candidiasis Therapeutics Market Size, 2018-2030
6.5.8 Nordic Countries Candidiasis Therapeutics Market Size, 2018-2030
6.5.9 Benelux Candidiasis Therapeutics Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Candidiasis Therapeutics Revenue, 2018-2030
6.6.2 By Region - Asia Candidiasis Therapeutics Sales, 2018-2030
6.6.3 China Candidiasis Therapeutics Market Size, 2018-2030
6.6.4 Japan Candidiasis Therapeutics Market Size, 2018-2030
6.6.5 South Korea Candidiasis Therapeutics Market Size, 2018-2030
6.6.6 Southeast Asia Candidiasis Therapeutics Market Size, 2018-2030
6.6.7 India Candidiasis Therapeutics Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Candidiasis Therapeutics Revenue, 2018-2030
6.7.2 By Country - South America Candidiasis Therapeutics Sales, 2018-2030
6.7.3 Brazil Candidiasis Therapeutics Market Size, 2018-2030
6.7.4 Argentina Candidiasis Therapeutics Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Candidiasis Therapeutics Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Candidiasis Therapeutics Sales, 2018-2030
6.8.3 Turkey Candidiasis Therapeutics Market Size, 2018-2030
6.8.4 Israel Candidiasis Therapeutics Market Size, 2018-2030
6.8.5 Saudi Arabia Candidiasis Therapeutics Market Size, 2018-2030
6.8.6 UAE Candidiasis Therapeutics Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Candidiasis Therapeutics Major Product Offerings
7.1.4 Novartis AG Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Candidiasis Therapeutics Major Product Offerings
7.2.4 Amgen Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Company Summary
7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
7.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.4 Bayer-Algeta
7.4.1 Bayer-Algeta Company Summary
7.4.2 Bayer-Algeta Business Overview
7.4.3 Bayer-Algeta Candidiasis Therapeutics Major Product Offerings
7.4.4 Bayer-Algeta Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.4.5 Bayer-Algeta Key News & Latest Developments
7.5 Merrion Pharmaceuticals Plc.
7.5.1 Merrion Pharmaceuticals Plc. Company Summary
7.5.2 Merrion Pharmaceuticals Plc. Business Overview
7.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Major Product Offerings
7.5.4 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.5.5 Merrion Pharmaceuticals Plc. Key News & Latest Developments
7.6 Ablynx
7.6.1 Ablynx Company Summary
7.6.2 Ablynx Business Overview
7.6.3 Ablynx Candidiasis Therapeutics Major Product Offerings
7.6.4 Ablynx Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.6.5 Ablynx Key News & Latest Developments
7.7 Genta Incorporated
7.7.1 Genta Incorporated Company Summary
7.7.2 Genta Incorporated Business Overview
7.7.3 Genta Incorporated Candidiasis Therapeutics Major Product Offerings
7.7.4 Genta Incorporated Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.7.5 Genta Incorporated Key News & Latest Developments
7.8 Galapagos NV
7.8.1 Galapagos NV Company Summary
7.8.2 Galapagos NV Business Overview
7.8.3 Galapagos NV Candidiasis Therapeutics Major Product Offerings
7.8.4 Galapagos NV Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.8.5 Galapagos NV Key News & Latest Developments
7.9 Catena Pharmaceuticals Inc.
7.9.1 Catena Pharmaceuticals Inc. Company Summary
7.9.2 Catena Pharmaceuticals Inc. Business Overview
7.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Major Product Offerings
7.9.4 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.9.5 Catena Pharmaceuticals Inc. Key News & Latest Developments
7.10 Digna Biotech S.L.
7.10.1 Digna Biotech S.L. Company Summary
7.10.2 Digna Biotech S.L. Business Overview
7.10.3 Digna Biotech S.L. Candidiasis Therapeutics Major Product Offerings
7.10.4 Digna Biotech S.L. Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.10.5 Digna Biotech S.L. Key News & Latest Developments
7.11 Medivir AB
7.11.1 Medivir AB Company Summary
7.11.2 Medivir AB Candidiasis Therapeutics Business Overview
7.11.3 Medivir AB Candidiasis Therapeutics Major Product Offerings
7.11.4 Medivir AB Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.11.5 Medivir AB Key News & Latest Developments
7.12 Amura Holdings
7.12.1 Amura Holdings Company Summary
7.12.2 Amura Holdings Candidiasis Therapeutics Business Overview
7.12.3 Amura Holdings Candidiasis Therapeutics Major Product Offerings
7.12.4 Amura Holdings Candidiasis Therapeutics Sales and Revenue in Global (2018-2023)
7.12.5 Amura Holdings Key News & Latest Developments
8 Global Candidiasis Therapeutics Production Capacity, Analysis
8.1 Global Candidiasis Therapeutics Production Capacity, 2018-2030
8.2 Candidiasis Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Candidiasis Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Candidiasis Therapeutics Supply Chain Analysis
10.1 Candidiasis Therapeutics Industry Value Chain
10.2 Candidiasis Therapeutics Upstream Market
10.3 Candidiasis Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Candidiasis Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Candidiasis Therapeutics in Global Market
Table 2. Top Candidiasis Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Candidiasis Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Candidiasis Therapeutics Revenue Share by Companies, 2018-2023
Table 5. Global Candidiasis Therapeutics Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Candidiasis Therapeutics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Candidiasis Therapeutics Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Candidiasis Therapeutics Product Type
Table 9. List of Global Tier 1 Candidiasis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Candidiasis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Candidiasis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Candidiasis Therapeutics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Candidiasis Therapeutics Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Candidiasis Therapeutics Sales (K Pcs), 2018-2023
Table 15. By Type - Global Candidiasis Therapeutics Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Candidiasis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Candidiasis Therapeutics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Candidiasis Therapeutics Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Candidiasis Therapeutics Sales (K Pcs), 2018-2023
Table 20. By Application - Global Candidiasis Therapeutics Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Candidiasis Therapeutics Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Candidiasis Therapeutics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Candidiasis Therapeutics Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Candidiasis Therapeutics Sales (K Pcs), 2018-2023
Table 25. By Region - Global Candidiasis Therapeutics Sales (K Pcs), 2024-2030
Table 26. By Country - North America Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Candidiasis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Candidiasis Therapeutics Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Candidiasis Therapeutics Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Candidiasis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Candidiasis Therapeutics Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Candidiasis Therapeutics Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Candidiasis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Candidiasis Therapeutics Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Candidiasis Therapeutics Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Candidiasis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Candidiasis Therapeutics Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Candidiasis Therapeutics Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Candidiasis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Candidiasis Therapeutics Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Candidiasis Therapeutics Sales, (K Pcs), 2024-2030
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Candidiasis Therapeutics Product Offerings
Table 48. Novartis AG Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Candidiasis Therapeutics Product Offerings
Table 52. Amgen Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Ltd. Company Summary
Table 55. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Offerings
Table 56. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 58. Bayer-Algeta Company Summary
Table 59. Bayer-Algeta Candidiasis Therapeutics Product Offerings
Table 60. Bayer-Algeta Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Bayer-Algeta Key News & Latest Developments
Table 62. Merrion Pharmaceuticals Plc. Company Summary
Table 63. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Offerings
Table 64. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Merrion Pharmaceuticals Plc. Key News & Latest Developments
Table 66. Ablynx Company Summary
Table 67. Ablynx Candidiasis Therapeutics Product Offerings
Table 68. Ablynx Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Ablynx Key News & Latest Developments
Table 70. Genta Incorporated Company Summary
Table 71. Genta Incorporated Candidiasis Therapeutics Product Offerings
Table 72. Genta Incorporated Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Genta Incorporated Key News & Latest Developments
Table 74. Galapagos NV Company Summary
Table 75. Galapagos NV Candidiasis Therapeutics Product Offerings
Table 76. Galapagos NV Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Galapagos NV Key News & Latest Developments
Table 78. Catena Pharmaceuticals Inc. Company Summary
Table 79. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Offerings
Table 80. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Catena Pharmaceuticals Inc. Key News & Latest Developments
Table 82. Digna Biotech S.L. Company Summary
Table 83. Digna Biotech S.L. Candidiasis Therapeutics Product Offerings
Table 84. Digna Biotech S.L. Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Digna Biotech S.L. Key News & Latest Developments
Table 86. Medivir AB Company Summary
Table 87. Medivir AB Candidiasis Therapeutics Product Offerings
Table 88. Medivir AB Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Medivir AB Key News & Latest Developments
Table 90. Amura Holdings Company Summary
Table 91. Amura Holdings Candidiasis Therapeutics Product Offerings
Table 92. Amura Holdings Candidiasis Therapeutics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Amura Holdings Key News & Latest Developments
Table 94. Candidiasis Therapeutics Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 95. Global Candidiasis Therapeutics Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Candidiasis Therapeutics Production by Region, 2018-2023 (K Pcs)
Table 97. Global Candidiasis Therapeutics Production by Region, 2024-2030 (K Pcs)
Table 98. Candidiasis Therapeutics Market Opportunities & Trends in Global Market
Table 99. Candidiasis Therapeutics Market Drivers in Global Market
Table 100. Candidiasis Therapeutics Market Restraints in Global Market
Table 101. Candidiasis Therapeutics Raw Materials
Table 102. Candidiasis Therapeutics Raw Materials Suppliers in Global Market
Table 103. Typical Candidiasis Therapeutics Downstream
Table 104. Candidiasis Therapeutics Downstream Clients in Global Market
Table 105. Candidiasis Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Candidiasis Therapeutics Segment by Type in 2022
Figure 2. Candidiasis Therapeutics Segment by Application in 2022
Figure 3. Global Candidiasis Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Candidiasis Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Candidiasis Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. Candidiasis Therapeutics Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Candidiasis Therapeutics Revenue in 2022
Figure 9. By Type - Global Candidiasis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 11. By Type - Global Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 12. By Type - Global Candidiasis Therapeutics Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Candidiasis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Application - Global Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 16. By Application - Global Candidiasis Therapeutics Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Candidiasis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Candidiasis Therapeutics Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 20. By Region - Global Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 21. By Country - North America Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 22. By Country - North America Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 23. US Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 28. Germany Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. France Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 37. China Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. India Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 43. By Country - South America Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 44. Brazil Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Candidiasis Therapeutics Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Candidiasis Therapeutics Sales Market Share, 2018-2030
Figure 48. Turkey Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Candidiasis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 52. Global Candidiasis Therapeutics Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Candidiasis Therapeutics by Region, 2022 VS 2030
Figure 54. Candidiasis Therapeutics Industry Value Chain
Figure 55. Marketing Channels
